期刊文献+

改良体外成熟培养——多囊卵巢综合征患者助孕治疗的有效替代方案 被引量:5

Modified in-vitro maturation—a effective and alternative protocol for treatment patients with polycystic ovary syndrome
下载PDF
导出
摘要 目的比较多囊卵巢综合征(PCOS)患者三种助孕方案的治疗效果。方法回顾性分析2010年1月至2011年5月在本院助孕的PCOS患者,按接受的助孕方式分为三组:A组(n=97),自然周期卵母细胞体外成熟培养(IVM);B组(n=33),降调节后短暂促性腺激素(Gn)刺激再IVM;C组(n=112),长方案降调节后常规体外受精-胚胎移植(IVF-ET)助孕。比较三种助孕方案治疗效果。结果 B组和C组临床妊娠率无显著统计学差异(58.1%vs.57.7%,P>0.05),但均显著高于A组(32.5%)(P<0.05)。hCG日内膜厚度分别为A组(6.1±1.8)mm,B组(8.8±2.3)mm和C组(11.6±2.5)mm,三组间比较均有统计学差异(P<0.05)。A组未使用Gn,B组Gn用量为(578.1±314.4)IU,费用为(2,029.6士1204.8)元,C组Gn用量(1,751.1±692.8)IU,费用(5,768.4±2,100.8)元,三组比较均有统计学差异(P<0.05)。A、B组无卵巢过度刺激综合征(OHSS)发生,C组重度OHSS发生率为4.5%。结论 IVM助孕可以避免OHSS发生,若降调节后短暂Gn刺激再IVM助孕,由于子宫内膜发育得到改善,可以获得与长方案相似的临床妊娠率,是PCOS患者的一个经济安全有效的助孕方式选择。 Objective: To compare the effectiveness of three strategies of in in-vitro fertilization (IVF) for treatment of women with polycystic ovary syndrome (PCOS). Methods: The clinical data of 242 patients with PCOS in our hospital from 2010 January to 2011 May were analyzed retrospectively. The patients were divided into three groups: 97 patients received in vitro maturation CIVM) in natural cycles (group A), 33 patients received IVM after down regulation and shortly gonadotropin (Gn) stimulation (group B) and 112 patients received regular IVF after long-term protocol (group C). Results: The clinical pregnancy rate in group B (58. 1%) and group C (57. 7%) were significant higher than that in group A (32.5%) (P〈0.05). The endometrial thickness on hCG day in group A, B and C was (6.1±1.8)mm, (8.8±2.3)mm and (11.6±2.5)mm respectively, which showed significant differences between any two groups. Patients in group A did not receive Gn injection. In group B, Gn dosage was (578. 1± 314. 4) IU and overall cost for controlled ovary hyperstimulation (COH) was (2029. 6±1204. 8)RMB. In group C, Gn dosage was (1751. 1 ± 692. 8)IU and overall cost was (5768.4±2100.8)RMB. There were significant differences between any two groups (P〈0.05). None of the patients in group A and group B occurred ovarian hyper-stimulation syndrome (OHSS), the severe OHSS in group C was 4.5%. Conclusions: IVM after down regulation and short Gn stimulation is a safer and cost-effective protocol for treatment of patients with PCOS to prevent severe OHSS and improve pregnancy rate comparing to routine IVM.
出处 《生殖医学杂志》 CAS 2012年第5期423-426,共4页 Journal of Reproductive Medicine
  • 相关文献

参考文献19

  • 1陈子江.多囊卵巢综合征相关病因及临床研究——来自山东大学生殖医学中心的报告[J].生殖医学杂志,2007,16(4):232-235. 被引量:45
  • 2邵明君,叶碧绿,赵军招,林金菊,林文琴,黄学锋.体外受精-胚胎移植在多囊卵巢综合征不育患者中的应用[J].生殖医学杂志,2005,14(1):10-12. 被引量:20
  • 3Trounson A, Wood C, Kausche A. In vitro maturation and the fertilization and developmental competence of oocytes recoverd from untreated polycystie ovarian patients[J]. Fertil Steril, 1994,62(2) :353-362.
  • 4Le Du A, Kadoeh [J, Bourcigaux N, et al. In vitro oocyte maturation for the treatment o infertility associated with polycystic ovarian syndrome. The French experience ['J]. Hum Reprod, 2005, 20(2): 420-424.
  • 5刘嘉茵,钱云,冒韵东,丁卫,杨乃明.人未成熟卵母细胞体外培养成熟、受精及胚胎移植[J].中华妇产科杂志,2003,38(4):230-232. 被引量:37
  • 6Huang JY, Chian RC, Tan SL. Ovarian hyperstimulation syndrome prevention strategies: in vitro maturation E J 1. Semin Reprod Med, 2010, 28(6):519-531.
  • 7Chian RC, Bucket WM, Tulandi T, et al. Prospective randomized study of human ehorionic gonadotrophin priming before immature ooeyte retrieval from unstimulated women with polycystic ovarian syndrome[J]. Hum Reprod, 2000, 15(1) : 165-170.
  • 8Hreinsson J, Rosenlund B, LH is equally effective as Friden B, et al. Recombination recombinate HCG in promoting oocyte maturation in a clinical in-vitro maturation programme: a randomized study[J]. Hum Reprod, 2003, 18 (10): 2131-2136.
  • 9Child TJ, Abdu[Jalil AK, Gulekli B, et al. In vitro maturation and fertilization of ooeytes from unstimulated normal ovaries, polyeystic ovaries, and women with polyeystie ovary syndrome[J]. Fertil Steril, 2001, 76 (5) 936-942.
  • 10Wynn P, Picton HM, Krapez JA, et al. Pretreatment with follicle stimulating hormone promotes the numbers of human oocytes reaching metaphase II by in-vitro maturation[J]. Hum Reprod, 1998, 13 (11): 3132-3138.

二级参考文献39

共引文献96

同被引文献61

  • 1金仁桃,刘雨生,童先宏,骆丽华,郭通航,周桂香,栾红兵.卵母细胞体外成熟预防卵巢过度刺激综合征的应用[J].现代妇产科进展,2007,16(7):514-516. 被引量:6
  • 2Li R,Zhang Q,Yang D,et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study [J]. Hum Reprod, 2013,28(9 ) : 2562-2569.
  • 3Chen ZJ, Shi Y. Polycystic ovary syndrome [J]. Front Med China, 2010,4(3) :280-284.
  • 4Thessaloniki ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome[J]. Hum Reprod, 2008,23 ( 3 ) : 462-477.
  • 5Marcus SF, Ledger WL. Efficacy and safety of long-acting GnRH agonists in in vitro fertilization and embryo transfer [J]. Hum Fertil (Camb),2001,4(2) : 85-93.
  • 6Venetis CA,Kolibianakis EM,Bosdou JK,et al. Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles [J]. Hum Reprod Update, 2013,19 ( 5 ) : 433-457.
  • 7Elnashar AM. Progesterone rise on the day of HCG administration (premature luteinization) in tVF: an overdue update [J]. J Assist Reprod Genet, 2010,27 (4) : 149-155.
  • 8Lainas TG,Sfontouris IA,Zorzovilis IZ,et al. Flexible GnRH antagonist protocol versus GnRH agonist long protocol in patients with polycystic ovary syndrome treated for IVF: a prospective randomised controlled trial (RCT)[J]. Hum Reprod, 2010,25 (3) : 683-689.
  • 9Lin H,Li Y,Li L,et al. Is a GnRH antagonist protocol better in PCOS patients? A meta-analysis of RCTs [J]. PLoS One,2014,9 (3) : e91796.
  • 10Xiao J, Chen S, Zhang C, et al. Effectiveness of GnRH antagonist in the treatment of patients with polycystic ovary syndrome undergoing IVF: a systematic review and meta analysis[J]. Gynecol Endocrinol, 2013,29(3) : 187-191.

引证文献5

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部